GRDN
Income statement / Annual
Last year (2024), Guardian Pharmacy Services, Inc.'s total revenue was $1.23 B,
an increase of 17.42% from the previous year.
In 2024, Guardian Pharmacy Services, Inc.'s net income was -$87.29 M.
See Guardian Pharmacy Services, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.23 B |
$1.05 B |
$908.91 M |
$792.07 M |
$735.96 M |
$698.29 M |
$600.37 M |
| Cost of Revenue |
$984.04 M
|
$837.88 M
|
$723.04 M
|
$630.81 M
|
$588.96 M
|
$554.83 M
|
$477.33 M
|
| Gross Profit |
$244.37 M
|
$208.31 M
|
$185.87 M
|
$161.27 M
|
$147.00 M
|
$143.46 M
|
$123.03 M
|
| Gross Profit Ratio |
0.2
|
0.2
|
0.2
|
0.2
|
0.2
|
0.21
|
0.2
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
-$3.38 M
|
$13.03 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$137.26 M
|
$118.09 M
|
$102.54 M
|
$97.56 M
|
$87.85 M
|
| Selling, General & Administrative Expenses |
$307.29 M
|
$167.36 M
|
$133.88 M
|
$131.12 M
|
$102.54 M
|
$97.56 M
|
$87.85 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$12.40 M
|
$11.80 M
|
$9.26 M
|
| Operating Expenses |
$307.29 M
|
$167.36 M
|
$133.88 M
|
$131.12 M
|
$114.94 M
|
$109.36 M
|
$97.10 M
|
| Cost And Expenses |
$1.29 B
|
$1.01 B
|
$856.92 M
|
$761.92 M
|
$703.89 M
|
$664.19 M
|
$574.43 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$3.28 M
|
$2.86 M
|
$1.93 M
|
$1.64 M
|
$2.16 M
|
$2.25 M
|
$1.90 M
|
| Depreciation & Amortization |
$19.77 M
|
$18.23 M
|
$16.56 M
|
$16.53 M
|
$17.26 M
|
$15.85 M
|
$13.13 M
|
| EBITDA |
-$43.43 M |
$58.81 M |
$68.15 M |
$46.49 M |
$49.07 M |
$49.47 M |
$38.31 M |
| EBITDA Ratio |
-0.04
|
0.06
|
0.07
|
0.06
|
0.07
|
0.07
|
0.06
|
| Operating Income Ratio |
-0.05
|
0.04
|
0.06
|
0.04
|
0.04
|
0.05
|
0.04
|
| Total Other Income/Expenses Net |
-$3.56 M
|
-$3.23 M
|
-$2.33 M
|
-$1.82 M
|
-$2.40 M
|
-$2.73 M
|
-$2.66 M
|
| Income Before Tax |
-$66.48 M
|
$37.72 M
|
$49.66 M
|
$28.33 M
|
$29.66 M
|
$31.37 M
|
$23.27 M
|
| Income Before Tax Ratio |
-0.05
|
0.04
|
0.05
|
0.04
|
0.04
|
0.04
|
0.04
|
| Income Tax Expense |
$4.56 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$87.29 M
|
$23.90 M
|
$35.42 M
|
$16.31 M
|
$19.94 M
|
$21.75 M
|
$14.68 M
|
| Net Income Ratio |
-0.07
|
0.02
|
0.04
|
0.02
|
0.03
|
0.03
|
0.02
|
| EPS |
-1.41 |
0.39 |
0.58 |
0.27 |
0.33 |
0.36 |
0.24 |
| EPS Diluted |
-1.41 |
0.39 |
0.58 |
0.27 |
0.33 |
0.36 |
0.24 |
| Weighted Average Shares Out |
$62.01 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
| Weighted Average Shares Out Diluted |
$62.01 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
$60.84 M
|
| Link |
|
|
|
|
|
|
|
